Faculty Profile

Mani A. Daneshmand, MD

Mani A. Daneshmand, MD

Andrew J. McKelvey Professor

Associate Professor of Surgery, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine

Director, Emory Heart & Lung Transplantation and Mechanical Circulatory Support

Director, Emory ECMO (Extracorporeal Membrane Oxygenation) Program

Associate Program Director, Cardiothoracic Residency, Emory University SOM




American Board of Surgery, American Board of Thoracic Surgery

Year Joined Emory as a Faculty Member



In 2019, Emory's heart and lung transplant, mechanical circulatory, and ECMO programs were consolidated into one comprehensive program with Dr. Daneshmand as director, improving care coordination for patients and their families and providing world-class transplant and life support services.

Prior to joining Emory, Dr. Daneshmand was surgical director of lung and heart-lung transplantation and surgical director of the Extracorporeal Life Support Program at Duke University Medical Center. He was also program director of Duke's advanced cardiac and thoracic organ transplant surgery fellowship.

Dr. Daneshmand's research interests focus on the causes of and treatments for advanced heart and lung failure to identify new therapies for these diseases. These include new medications; such treatments as extracorporeal membrane oxygenation (ECMO), a device similar to the heart-lung bypass machine that provides advanced life support to patients with lung and/or heart complications; mechanical pumps such as ventricular assist devices that can stand alone or act as a bridge to heart transplant; and organ transplantation for patients suffering from end-stage organ failure.


View Dr. Daneshmand's publications in PubMed.


  • Emory University Hospital

  • Emory University Hospital Midtown

  • Grady Memorial Hospital

  • Emory Saint Joseph's Hospital

  • Atlanta VA Healthcare System


  • MD, Albany Medical College, Class of 2004

  • General Surgery Residency, Department of Surgery, Duke University Medical Center, 2004-2006, 2008-2011

  • Cardiothoracic Surgery Research Fellowship, Duke University Medical Center, 2006-2008

  • Cardiothoracic Surgery Clinical Fellowship, Duke University Medical Center, 2009-2013

Honors and Awards

  • Kamal Mansour, MD, Teaching Award, Emory University Cardiothoracic Surgery Residency, 2020

  • Finalist, 13th Annual C. Walton Lillehei Resident Forum Research Competition, 2010

  • Finalist, Young Innovators Fellowship, American Society for Artificial Internal Organs, 2008

  • Medforte Innovation Award, American Society for Artificial Internal Organs, 2006

  • William P. J. Peete Award: Outstanding First Year Surgical Resident, Duke University Medical Center, 2005

  • Ralph Alley Prize: Outstanding Performance in Cardiothoracic Surgery, Albany Medical College, 2004

Current Organizational Memberships

  • American College of Surgeons: Fellow

  • 21st Century Cardiothoracic Surgical Society

  • American Heart Association

  • American Association for Thoracic Surgery

  • South Atlantic Cardiovascular Society

  • Eastern Cardiothoracic Surgical Society

  • Extracorporeal Life Support Organization

  • Society of Thoracic Surgeons

  • Southern Thoracic Surgical Association

  • International Society for Heart and Lung Transplantation

  • American Society for Artificial Internal Organs

  • Omicron Delta Epsilon-National Economics Honors Society
  • American Medical Student Association

  • American Medical Association

Clinical Interests

  • Adult cardiac surgery

  • Surgical management of heart failure

  • Aortic surgery

  • Minimally invasive cardiac surgery

  • Cardiac and pulmonary transplantation

  • Mechanical circulatory support, extracorporeal membrane oxygenation (ECMO), ventricular assist devices (VAD)

Research Interests

  • The mechanisms and treatment of end-stage heart and lung failure

  • Deployment of data mining and analysis to better understand trends and clinical patterns within patients with end-stage heart and lung failure, with the ultimate goal of innovating tools and/or treatments that will positively impact survival